Literature DB >> 6090339

Molecular size variation of EBNA is determined by the EB viral genome.

L Gergely, L Sternås, J Dillner, G Klein.   

Abstract

The size classes of the Epstein-Barr virus(EBV)-induced nuclear antigen (EB-NA) have been determined in EBV-carrying sublines of two originally EBV-negative Burkitt lymphomas, converted in vitro by two different EBV substrains, and in somatic hybrids between two EBV-carrying cell lines or between an EBV-positive and an EBV-negative line. Partially purified EBNA components were detected by Western blotting and subsequent exposure to antiserum/alkaline-phosphatase-coupled protein A complexes. Converted Ramos and BJAB sublines contained the main EBNA components characteristic for the virus donor strain. The EBNA components of the Ramos and BJAB cells converted by P3HR-1 virus were similar to each other and to the components of the P3HR-1 donor cell, whereas the EBNA of the cells converted by B95-8 virus resembled the B95-8 donor line. It was concluded that the size variation of EBNA is determined by the viral genome. The parental lines of the somatic hybrids studied (Raji, P3HR-1, Namalwa and Daudi) contained EBNA components of different molecular weight (MW) classes. The higher MW forms ranged from 70K to 80K. Several distinctive lower MW components also were present. The somatic hybrids expressed the main EBNA components of both parental lines. Hybrids between EBV-carrying and EBV-genome-negative lines contained the characteristic EBNA component of the EBV-positive parent. It was concluded that the size variation of EBNA is under strict genetic control which prevails in the hybrids in a codominant fashion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090339     DOI: 10.1159/000149538

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  5 in total

1.  Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers.

Authors:  M L Lung; R S Chang; J H Jones
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

2.  Numerous length polymorphisms at short tandem repeats in human cytomegalovirus.

Authors:  C L Davis; D Field; D Metzgar; R Saiz; P A Morin; I L Smith; S A Spector; C Wills
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.

Authors:  B Contreras-Salazar; G Klein; M G Masucci
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity.

Authors:  Agnes Mwakingwe-Omari; Sara A Healy; Jacquelyn Lane; David M Cook; Sahand Kalhori; Charles Wyatt; Aarti Kolluri; Omely Marte-Salcedo; Alemush Imeru; Martha Nason; Lei K Ding; Hope Decederfelt; Junhui Duan; Jillian Neal; Jacob Raiten; Grace Lee; Jen C C Hume; Jihyun E Jeon; Ijeoma Ikpeama; Natasha Kc; Sumana Chakravarty; Tooba Murshedkar; L W Preston Church; Anita Manoj; Anusha Gunasekera; Charles Anderson; Sean C Murphy; Sandra March; Sangeeta N Bhatia; Eric R James; Peter F Billingsley; B Kim Lee Sim; Thomas L Richie; Irfan Zaidi; Stephen L Hoffman; Patrick E Duffy
Journal:  Nature       Date:  2021-06-30       Impact factor: 49.962

5.  Antibodies to the second Epstein-Barr virus nuclear antigen in non-Hodgkin lymphomas.

Authors:  L Gergely; J Czeglédy; L Váczi; K Pálóczi; G Szegedi
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.